PATENT CLAIM ANALYSIS

Application Number: 15747433
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "04400A"]

Abstract:
The present disclosure provides methods of reducing protein misfolding and/or aggregation in a cell. The present disclosure provides methods of treating diseases and disorders associated with protein misfolding and/or aggregation.

Claim (Index 17):
The method of  claim 16 , wherein the CPT inhibitor is etomoxir, perhexiline, oxfenicine, or mildronate.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.52381
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14239198', '11282262', '11671991', '13379241', '13476790']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7264243454032747
- 35 USC 102 Novelty (BERT): 0.4871381767509583
- Combined Prediction Score: 0.7024957285380431
- Mean Citation Score: 113.59821200000002
- Max Citation Score: 140.24664
- Similarity Product: 89.77971565638543

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test